Product Information
ESOMEPRAZOLE MAG DR 20 MG CAP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1446 per EA under NDC 00378235077. Its NADAC has been published 549 times since Mar 30, 2016.
FDA first approved this application on Aug 2, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378235077
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESOMEPRAZOLE MAGNESIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078936FDA Approved
8/2/2015
TE Code
AB
On Market Since
8/3/2015
Pharmacological Classes
Price Statistics
The NADAC for ESOMEPRAZOLE MAG DR 20 MG CAP has been published 549 times since Mar 30, 2016, and over the history we have for it it has declined 95.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1446 per EA |
|---|---|
| All-time high | $3.5301 (Apr 13, 2016) |
| All-time low | $0.1307 (Nov 20, 2024) |
| 52-week high | $0.1690 |
| 52-week low | $0.1446 |
| Median price | $0.2716 |
| Average price | $0.4785 |
| Largest weekly change | +31.8% (Aug 21, 2024) |
| Weeks tracked | 549 |
| Tracking since | Mar 30, 2016 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Esomeprazole Magnesium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESOMEPRAZOLE MAG DR 20 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ESOMEPRAZOLE MAG DR 20 MG CAP, manufactured by Mylan Pharmaceuticals Inc., is $0.1446 per EA (NDC 00378235077), effective Sep 30, 2026.
How has the price of ESOMEPRAZOLE MAG DR 20 MG CAP changed over time?
Over the history we have for it, the NADAC for ESOMEPRAZOLE MAG DR 20 MG CAP has declined 95.9%. It has been tracked across 549 weekly CMS publications since Mar 30, 2016.
What are the highest and lowest recorded NADAC prices for ESOMEPRAZOLE MAG DR 20 MG CAP?
Since Mar 30, 2016, the NADAC for ESOMEPRAZOLE MAG DR 20 MG CAP has ranged from a low of $0.1307 (Nov 20, 2024) to a high of $3.5301 (Apr 13, 2016), with a median of $0.2716 per EA.
Are there cheaper alternatives to ESOMEPRAZOLE MAG DR 20 MG CAP?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESOMEPRAZOLE MAG DR 20 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures ESOMEPRAZOLE MAG DR 20 MG CAP?
ESOMEPRAZOLE MAG DR 20 MG CAP (NDC 00378235077) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.